Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
A top US Food and Drug Administration (FDA) official stated that the midterm congressional election results will not likely ...
As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' ...
A top US Food and Drug Administration (FDA) enforcement official announced that the agency conducted more unannounced drug ...
BARCELONA – As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' jobs but will instead help them work more efficiently and dedicate ...
Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product ...
Sponsored Content] Health Canada’s 14 September 2026 interim policy introduces flexibility in ethics reporting, investigator ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on ...
The US Food and Drug Administration (FDA) on Tuesday issued draft guidance on submitting investigational device exemption ...
The US Food and Drug Administration (FDA) on Tuesday issued draft guidance laying out its proposed regulatory approach to ...
Patients who reviewed and signed a patient agreement form (PAF) for mifepristone and misoprostol under the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results